Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04665843 |
|---|---|
| Brief Title: | A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck (SKYSCRAPER-09) |
| First Submitted : | December 7, 2020 |
| First Submitted that Met QC Criteria : | December 7, 2020 |
| First Posted : | December 14, 2020 |
| Last Update Submitted that Met QC Criteria : | December 9, 2022 |
| Last Update Posted : | December 12, 2022 |